The authors also assessed the serum levels of inflammatory cytokines: IL-6 and IL-17, which were found to be correlated with the levels of serum lipids, suggesting the involvement of the inflammatory status of MS in the pathogenesis of impaired lipid metabolism [27]. This evidence concerns the gene IL6 and myeloid sarcoma.